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Abstract
Background: Severe complicated intra-abdominal sepsis (SCIAS) is a worldwide challenge with increasing incidence.
Open abdomen management with enhanced clearance of fluid and biomediators from the peritoneum is a potential
therapy requiring prospective evaluation. Given the complexity of powering multi-center trials, it is essential to recruit an
inception cohort sick enough to benefit from the intervention; otherwise, no effect of a potentially beneficial therapy may
be apparent. An evaluation of abilities of recognized predictive systems to recognize SCIAS patients was conducted using
an existing intra-abdominal sepsis (IAS) database.
Methods: All consecutive adult patients with a diffuse secondary peritonitis between 2012 and 2013 were collected from
a quaternary care hospital in Finland, excluding appendicitis/cholecystitis. From this retrospectively collected database, a
target population (93) of those with either ICU admission or mortality were selected. The performance metrics of the
Third Consensus Definitions for Sepsis and Septic Shock based on both SOFA and quick SOFA, the World Society of
Emergency Surgery Sepsis Severity Score (WSESSSS), the APACHE II score, Manheim Peritonitis Index (MPI), and the
Calgary Predisposition, Infection, Response, and Organ dysfunction (CPIRO) score were all tested for their discriminant
ability to identify this subgroup with SCIAS and to predict mortality.
Results: Predictive systems with an area under-the-receiving-operating characteristic (AUC) curve > 0.8 included SOFA,
Sepsis-3 definitions, APACHE II, WSESSSS, and CPIRO scores with the overall best for CPIRO. The highest identification rates
were SOFA score ≥ 2 (78.4%), followed by the WSESSSS score ≥ 8 (73.1%), SOFA ≥ 3 (75.2%), and APACHE II ≥ 14 (68.8%)
identification. Combining the Sepsis-3 septic-shock definition and WSESSS ≥ 8 increased detection to 80%. Including
CPIRO score ≥ 3 increased this to 82.8% (Sensitivity-SN; 83% Specificity-SP; 74%. Comparatively, SOFA ≥ 4 and
WSESSSS ≥ 8 with or without septic-shock had 83.9% detection (SN; 84%, SP; 75%, 25% mortality).
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Conclusions: No one scoring system behaves perfectly, and all are largely dominated by organ dysfunction. Utilizing
combinations of SOFA, CPIRO, and WSESSSS scores in addition to the Sepsis-3 septic shock definition appears to offer
the widest “inclusion-criteria” to recognize patients with a high chance of mortality and ICU admission.
Trial registration: https://clinicaltrials.gov/ct2/show/NCT03163095; Registered on May 22, 2017.
Keywords: Intra-abdominal sepsis, Septic shock, Risk stratification, Randomized controlled trial, Trial methodology,
Organ dysfunction, Epidemiology
Background
Sepsis is a complex and increasing global health problem
[1–5]. International consensus currently uses the work-
ing definition of sepsis as life-threatening organ dysfunc-
tion caused by a dysregulated host response to infection
[2]. The number of cases per year is estimated as ap-
proaching 18–19 million worldwide [4–6]. In the most
severe cases, mortality rates approach 30–40% when
shock is present [2, 7, 8], although may be 80% in the
developing world [9]. When the focus of infection is
located within the abdominal cavity, a particularly severe
form of sepsis may result in association with the
anatomy and physiology of the abdominal cavity and the
viscera within [10, 11]. Cases of intra-abdominal sepsis
(IAS) may be defined as complicated when the inflam-
mation or contamination spreads beyond a single organ
[12, 13]. Complicated IAS may also be considered severe
complicated IAS (SCIAS) when organ dysfunction is
present with a mortality rate of 10–30% or with a
mortality rate of 40–70% [14, 15] when septic shock is
present [2, 7, 16, 17].
Despite advances in diagnosis, surgery, and antimicro-
bial therapy, mortality rates associated with CIAS and
IAS remain exceedingly high [18]. Despite appropriate
therapy, progress to septic shock and multiple organ
dysfunction driven by inflammation is common. Delayed
or inadequate source control remains an independent
predictor of mortality [19, 20]. However, recognizing
“failed source control” [21, 22], from a self-propagating
biomediator storm is often difficult or impossible
without abdominal re-exploration (relaparotomy). At
present, pharmacologic approaches are not the answer.
Attempting to derive pharmacologic therapies for com-
bating post-infective inflammation has proven an expen-
sive and frustrating process [23]. Over 100 attempts at
blocking single biological response mediators have failed
to address the early cytokine storm of sepsis [24, 25]. A
controversial, potentially morbid, potentially life-saving
technique is the adoption of an open abdomen (OA)
following source control laparotomy. Uncontrolled use
of the OA following sepsis is increasingly being reported
as another potentially desirable option for the sickest
SCIAS patents [12, 21, 22, 26–28]. However, accepting
the OA is either potentially a life-saving intervention or
a morbid unnecessary procedure with increased risks of
complications such as enterocutaneous fistulae [29, 30];
an adequately powered prospective randomized con-
trolled trial is urgently required.
Given the complexity of adequately powering multi-
center trials, it is essential to recruit an inception cohort
of patients sick enough to benefit from the intervention;
otherwise, no effect of a potentially beneficial therapy
may be apparent. Many scoring systems have been
proposed for use in predicting clinical outcomes in the
critically ill. Potential systems that have been suggested
include the Acute Physiology and Chronic Health
Evaluation (APACHE II) [31–34], multiple organ failure
(MOF) scores [35], P-POSSUM [32, 36], Therapeutic
Intervention Scoring System (TISS-28) [37, 38], and the
National Early Warning Score (NEWS) definitions of
sepsis [39, 40]; some are more intended for sepsis specif-
ically such as the Sepsis Severity Score [33] and those
specifically intended to consider intra-abdominal path-
ology such as the Mannheim Peritonitis Index [41], the
World Society of Emergency Surgery Sepsis Severity
Score (WSESSSS) [7], and even systems intended for
pancreatitis such as the Ranson [42, 43] and Imrie [43]
scores [44]. However, none is currently accepted as be-
ing ideal for predicting outcomes in SCIAS [7]. We thus
conducted an evaluation of the abilities of recognized
predictive systems for clinical outcomes in SCIAS to de-
tect patients of interest using an existing IAS database.
Methods
A retrospectively collected database of SCIAS cases was
created at a quaternary care hospital in Helsinki,
Finland. This database enrolled all consecutive adult pa-
tients with a diffuse secondary peritonitis between 2012
and 2013, although cases of appendicitis or cholecystitis
were excluded. The institutional human research review
committee approved the study design, and as it was an ob-
servational retrospective cohort study, neither informed
consent nor ethics committee’s approval was required. An
attribute of this dataset was that intraoperative evaluations
for development of organ dysfunctions were performed.
Although this data has been previously published [45], for
the current project the original data was revisited and
updated regarding to new Sepsis-3 definitions of organ
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dysfunction. The demographics included in this database
have been previously described and were sufficient to
allow calculation of the Mannheim Peritonitis Index
(MPI), WSESSSS (Table 1), Calgary Predisposition,
Infection, Response, and Organ Dysfunction (CPIRO)
(Table 2), Acute Physiology and Chronic Health
Evaluation (APACHE) II, and the consensus definitions
and quick SOFA (qSOFA) score of the Sepsis-3
International Consensus Definitions. From this database, a
cohort of patients who either died or were admitted to the
intensive care unit were selected. Thereafter, the perform-
ance metrics of these putative predictive and scoring sys-
tems were tested (using a number of varying thresholds
within each system where appropriate) for their discrimin-
ant ability to identify SCIAS and, thereafter, predict ICU
admission or 30-day mortality. To assess whether utilizing
combinations of scoring systems provided additive pre-
dictive power, the performance of combinations of sys-
tems was also calculated. This was done through simple
mathematical addition of patient of interest recognition.
Potential combinations to test were selected based on
their being practically usable by on-call clinicians without
retrospective data or extensive laboratory results, an
acceptable AUROC (> 0.80) in our analysis reflecting a
practical combination of scores in terms of highest
sensitivity with a reasonable specificity. Analyses were per-
formed using SPSS© Statistics version 22 for Mac (IBM©,
Armonk, NY, USA). Sensitivity and specificity were calcu-
lated for each prognostic system. Receiving operating
characteristics (ROC) curves were plotted and area under
curve (AUC) calculated with 95% confidence interval (CI).
Results
In the original data set, there were 223 patients. Of these
patients, 33 (13.5%) died within 30-days and 72 (32.2%)
were admitted to the ICU. The target group of interest,
with either 30-day mortality or ICU admission, consti-
tuted 93 patients with a 22% mortality. The majority
(88%) of this group stayed in ICU more than 3 days and
had a mean highest SOFA score of 7.9 [median 8;
IQR 5–10]. Accounting for those that died in ICU, the
mean length of ICU stay was 7.8 days [median 5.0;
IQR 3–8.75], with 90% staying 3 or more days.
Overall predictive rates were tested for different thresh-
old values of the scoring systems: qSOFA ≥ 2; SOFA 2, 3,
4 and Sepsis-3 septic shock definition; MPI ≥ 30, 32, 34;
APACHE II ≥ 12, 14, 16; WSES ≥ 8, 9, 10; CPIRO ≥ 3, 4
(Table 3). In addition, the combined predictive capability
of using the scores together was also tested and are
reported in Table 4. Systems with a good (AUC > 0.8)
performance included the SOFA, Sepsis-3 sepsis classifica-
tion, APACHE II, WSESSSS, and CPIRO scores and over-
all; the greatest AUC was for the CPIRO score regardless
if the consideration was of patients requiring ICU admis-
sion and dying (Fig. 1) or just with mortality (Fig. 2).
While selecting all patients with diffuse secondary peri-
tonitis would yield greater enrollment, the disease severity
would include patients with lower mortality that may not
benefit from OA therapy. Thus, the most efficient identifi-
cation rates of the desired cohort for a single system was a
SOFA score ≥ 2 with 78.4% identification, followed by
SOFA ≥ 3 with 75.2%, WSESSSS score ≥ 8 with 73.1%, and
the APACHE II ≥ 14 with 68.8% identification (Table 1).
Combining predictive systems together improved the
identification rates (Table 4). Combining the Sepsis-3 sep-
tic shock definition with the WSESSS criteria increased
detection to the highest rate of 79.6%, a rate that was not
Table 1 World Society of Emergency Surgery Sepsis Severity
Score for complicated intra-abdominal infections
Clinical conditions at admission
Sepsis with organ dysfunction at admission 3 points
Septic shock (acute circulatory failure characterized
by persistent arterial hypotension) requiring
vasopressor agents
5 points
Setting of acquisition
Healthcare-associated infection 2 points
Origin of intra-abdominal infection
Colonic non-diverticular perforation peritonitis 2 points
Small bowel perforation peritonitis 3 points
Diverticular diffuse peritonitis 2 points
Post-operative diffuse peritonitis 2 points
Delay in source control
Delayed initial intervention (pre-operative
duration of peritonitis (localized or diffuse) > 24 h
3 points
Risk factor
Age > 70 2 points
Immunosuppression (chronic glucocorticoids,
immunosuppressive agents, chemotherapy,
lymphatic disease, virus)
3 points
Reproduced from Sartelli et al [7]
Table 2 Calgary Predisposition, Infection, Response, and Organ
Dysfunction (CPIRO)
Score Variable Point
Predisposition Age > 65 years 1
Comorbidities 1
Response Leukopenia 1
Hypothermia 1
Organ dysfunction Cardiovascular dysfunction 1
Respiratory dysfunction 1
Renal dysfunction 1
CNS dysfunction 1
Total 8
Table reproduced from Posadas-Calleja et al. [57]
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changed with the further addition of patients detected by
a CPIRO score of ≥ 4 (Table 1). However, when the
CPIRO was utilized with a threshold of 3 or greater, for an
inclusive criteria of Sepsis-3 septic shock OR WSESSS ≥ 8
or CPIRO ≥ 3, this resulted in a detection rate of the de-
sired population of 82.8%, with a sensitivity of 83% and a
74% specificity for detection of a population with the mor-
tality rate remaining 26%. The other highest combination
of scoring systems was combining a SOFA ≥ 4 with
WSESSSS ≥ 8 which had a slightly higher detection rate of
83.9%, with 84% sensitivity and 75% specificity in a
population with 25% mortality. This detection was
unchanged in either direction by adding the criterion of
septic shock.
Discussion
The Closed or Open after Laparotomy (COOL) for Source
Control in Severe Complicated Intra-abdominal Sepsis
Trial (https://clinicaltrials.gov/ct2/show/NCT03163095) is
a prospective multi-institutional worldwide study examin-
ing outcomes in those managed with primary fascial
closure or OA in SCIAS [46]. To properly power this trial,
Table 3 Predictive capabilities of potential COOL study sepsis and critical illness scoring systems using Helsinki outcomes data
System Identified Outcome mortality Sensitivity (%) Specificity (%) AUCb 95% CI
qSOFA ≥ 2 34 (36.6%) 13 (32%) 37 95 0.723 [0.653–0.792]
SOFA ≥ 2 72 (77.4%) 25 (27%) 77 83 0.825 [0.766–0.885]
SOFA ≥ 3 70 (75.3%) 24 (27%) 75 85
SOFA ≥ 4 60 (64.5%) 20 (28%) 65 91
Septic shocka 36 (38.7%) 15 (37%) 39 96 0.82 [0.761–0.88]
MPI ≥ 30 48 (51.6%) 21 (28%) 51 79 0.774 [0.713–0.835]
MPI ≥ 32 42 (45.2%) 18 (32%) 45 89
MPI ≥ 34 22 (23.7%) 9 (33%) 24 96
APACHE II ≥ 14 64 (68.8%) 24 (26%) 69 78 0.828 [0.775–0.881]
APACHE II ≥ 16 52 (55.9%) 20 (30%) 56 89
APACHE II ≥ 18 42 (45.2%) 19 (39%) 45 95
WSESSSS ≥ 8 68 (73.1%) 27 (27%) 73 76 0.809 [0.752–0.866]
WSESSSS ≥ 9 58 (62.4%) 24 (29%) 62 82
WSESSSS ≥ 10 47 (50.5%) 20 (32%) 51 88
CPIRO ≥ 3 54 (58.1%) 21 (31%) 58 90 0.856 [0.806–0.905]
CPIRO ≥ 4 28 (30.1%) 13 (42%) 30 98
Ninety-three patients were selected out of the database based on 30-day mortality or ICU admission
aAUC is for sepsis classification according to Sepsis-3 consensus definitions
bOnly one area under the curve (AUC) was calculated for each scoring system without thresholds within
Table 4 Combined predictive capabilities of potential COOL study sepsis and critical illness scoring systems using Helsinki
outcomes data
System Identified Outcome mortality Sensitivity (%) Specificity (%)
Septic shock
OR CPIRO ≥ 3
57 (61.3%) 21 (30%) 61 90
Septic shock
OR CPIRO ≥ 4
42 (45.2%) 17 (35%) 45 95
SOFA ≥ 4
OR CPIRO ≥ 3
65 (69.9%) 22 (27%) 70 87
SOFA >4 (4 OR greater here) ≥OR WSESSSS ≥ 8 78 (83.9%) 28 (25%) 84 75
Septic shock OR WSESSSS ≥ 8 74 (79.6%) 28 (26%) 80 75
Septic shock OR CPIRO ≥ 4 OR WSES ≥ 8 74 (79.6%) 28 (26%) 80 75
Septic shock OR CPIRO ≥ 3 OR WSES ≥ 8 77 (82.8%) 29 (26%) 83 74
Septic shock OR SOFA ≥ 4 60 (76.3%) 20 (28%) 65 91
Septic shock OR SOFA ≥ 4 OR WSES ≥ 8 78 (83.92%) 28 (25%) 84 75
Ninety-three patients were selected out of the database based on 30-day mortality or ICU admission
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it is necessary to utilize optimal and validated scoring
tool(s) to identify surgical patients with SCIAS at high risk
of death requiring ICU care early in their hospital course,
typically prior to ICU admission. Such potential tool(s)
should be easy to use and functional while still in the
operating room prior to potential formal primary fascial
closure. A remarkable variety of potential scoring systems
for predicting outcomes in relation to septic populations
have developed over time leading to a somewhat dis-
crepant epidemiological picture that is compounded by
the variety of populations and health care settings in
which they have been studied. Systems have been used for
Fig. 1 Area under the receiver-operating curve (AUC) for candidate scoring systems considering recruitment population of interest with ICU
Admission or mortality
Fig. 2 Area under the receiver-operating curve (AUC) for candidate scoring systems considering recruitment population of interest with
mortality only
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a variety of reasons including quality assessment and
audit, epidemiological reporting and comparison,
study recruitment and analysis, and outcome clinical
predictions [7, 28, 31–37, 39–44].
When interrogated against a cohort of SCIAS patients
recruited from an advanced health-care system, each
predictive model performed with different attributes.
Even considering a specific scoring tool, the specific tool
may have varying sensitivity and specificity for identify-
ing patients of interest depending on the threshold value
of the tool selected. Thus, no one scoring system be-
haved perfectly, and all appear to be largely dominated
by organ dysfunction with a modest increase in
detection provided by the inclusion of further patient
characteristics some of which may not be readily avail-
able pre-operatively before potential surgery and admis-
sion to ICU. Nonetheless in this population, patients
identified by the Sepsis-3 septic shock definition in
addition to the WSESSS criteria with a score of 8 or
greater had a detection rate of 80%. Adding the potential
increased detection of the CPIRO score ≥ 3 increased the
detection rate to 83%. Thus, the COOL investigators
decision to include any of the three identifying cri-
teria of Sepsis-3 septic shock criterion, WSESSSS ≥ 8,
or CPIRO ≥ 3 seems statistically justified based on
this analysis.
The strengths of the Helsinki dataset are that it in-
volves an inception cohort exclusively of patients with
IAS. A methodological concern involves the degree to
which scores developed for septic patients with a wide
range of precipitating causes will specifically identify pa-
tients with SCIAS. It is relevant to compare the specific
experiences of the Helsinki data with evaluations in
other general septic cohorts and especially cohorts of
those with SCIAS. Although sepsis has been thoroughly
studied in general critical care unit populations, accurate
data collection has been less well studied outside of the
ICU and early in intra-abdominal sepsis populations
[39]. Thus, the literature does not support any one scor-
ing or predictive systems as being established for use in
SCIAS (Table 5).
For practical discussion, it will be important to detect
potential enrollees on the ward and in the emergency
department prior to post-surgical ICU admission. A pre-
vious determination of predictive capabilities of patients
on the ward or emergency department with suspected
infection examined the Sepsis-1, Sepsis-3, and NEWS
definitions of sepsis [39, 40]. Szakmany and colleagues
concluded that the Sepsis-3 definition identified patients
with the highest risk. SOFA score and NEWS were bet-
ter predictors of poor outcome, while the SOFA score
appeared to be the best tool for identifying patients with
high risk of death and sepsis-induced organ dysfunction
[39]. Representative performance characteristics in this
cohort with sepsis from all causes found that there was
considerable overlap. Alternatively, application of SIRS-
based criteria (Sepsis-1) did not identify 105 (27.3%) pa-
tients, all of whom had evidence of acute organ dysfunction
[39]. This analysis again raised concerns about the perform-
ance of qSOFA as it only identified 13% of patients other-
wise diagnosed with sepsis, missed 30% of those with organ
dysfunction, and failed to predict mortality.
The COOL investigators were particularly interested
in evaluations of scoring systems involving SCIAS popu-
lations. While there have been numerous scores that
attempt to prognosticate outcomes for general septic
populations, focused studies in CIAS are fewer. In 1997,
Bosscha and colleagues, studying 50 patients, commen-
ted that there was no ideal and accepted predictive scor-
ing system for IAS and only the MPI and APACHE II
scores contributed independently to mortality prediction
[44]. A comparison of the attributes of APACHE II,
SAPS, sepsis score, MOF score, and TISS-28 in 145 pa-
tients with secondary peritonitis also concluded that the
APACHE II and TISS-28 were significantly better than
other systems and specifically criticized the power of the
MPI [37]. They also specifically recommended that com-
bining scoring systems together should be the standard
classification system for grading severity of IAS [44].
Hanisch and colleagues analyzed 382 patients with
“abdominal septic shock” in 2011 using the SOFA,
APACHE II, SAPS, and MODS score and concluded that it
was impossible to predict individual patient outcomes with
any certainty and that the APACHE II performed the worst
[47]. Concerns about APACHE, even the newest propri-
etary APACHE IV, were recently repeated by Chan and
colleagues in a 2016 retrospective cohort analysis of IAS
patients. They commented that the APACHE scores might
not accurately predict mortality in those requiring source
control laparotomies as the post-operative trajectory might
be greatly modulated by the surgical procedure [48]. Con-
currently, in 2014 Das and colleagues evaluated the SAPS,
APACHE-II, and P-POSSUM systems to identify high risk
surgical patients with intra-abdominal sepsis and planned
relaparotomy [32]. Contrary to these other experiences, the
APACHE II score was the best at predicting mortality in
this small series of 34 patients with a 21% mortality rate
[32]. However, although considered a good marker, the
APACHE II utility in peritonitis has been questioned be-
cause of the conundrum of using the APACHE II to evalu-
ate interventions despite the fact that interventions might
significantly alter many of the physiological variables re-
quired for its calculation [7]. The authors of the RELAP
trial [49] evaluated the APACHE II, SAPS, MPI, MODS,
SOFA, and acute part of the APACHE-II score and noted
that none were of clinical value to predict patients with a
need for relaparotomy for IAS control and modest abilities
in predicting in-hospital mortality [50].
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Table 5 Previous assessments of predictive capabilities of sepsis scoring systems
Population Inclusion criteria Scores tested Outcome 1 Outcome 2 (if applicable)
Ward or ED (n = 380)
Szakmany 2017 [39]
NEWS ≥ 3 30-day mortality Organ dysfunction
Sepsis-1 68% SENS
Sepsis-3 86% SENS
qSOFA ≥ 2 22% SENS 26% SENS
SOFA 0.70 AUC 86% SENS
SIRS 26% SENS
Sepsis-1 (severe) 92% SENS
NEWS > 6 41% SENS 36% SENS
0.59 AUC
Post-operative ICU patients
[44] (n = 50)
Peritonitis + IAS requiring ICU Multivariate Prediction of
in-hospital death
APACHE II HR 6.7 [95CI 2.7–17]
MPI HR 9.8 095CI 1.3–73]
SAPS NS
SSS NS
MOF NS
Ranson NS
Imrie NS
Predictions of death (day 1 SICU)
Post-operative SICU patients
(n = 145) Delibegovic 2011 [37]
Non-traumatic secondary
peritonitis requiring
laparotomy
TISS-28 AUC 0.87
APACHE II AUC 0.86
MODS AUC 0.83
SAPS AUC 0.83
MPI AUC 0.72
SSS AUC 0.70
Abdominal septic shock in ICU
(n = 382) Hanisch 2011 [47]
Sepsis-1 criteria [61] for
abdominal septic shock
SOFA Death prediction first 3 ICU days 0.54 AUC
APACHE II 0.52 AUC
SAPS 0.52 AUC
MODS 0.52 AUC
IAS pts requiring SCL
(n = 211) Chan [48]
SCL and severe sepsis or
septic shock as per
Sepsis-1 (61)
APACHE-IV Predicted mortality rate 0.67 AUC
IAS pts requiting re-laparotomy
(n = 34) Das [32]
Secondary peritonitis APACHE-II Hospital mortality prediction 0.958 AUC
SAPS-II 0.955 AUC
P-POSSUM 0.931 AUC
IAS pts undergoing SCL
(n = 221) Van Ruler [50]
APACHE > 10 Mortality Need for Re-Laparotomy
APACHE-II 0.74 AUC 0.49 AUC
SAPS-II 0.80 AUC 0.56 AUC
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The Predisposition, Infection, Response and Organ dys-
function (PIRO) staging system was designed as a stratifi-
cation tool to deal with the inherent heterogeneity of
septic patients [51]. The concept dates from recommenda-
tions made in the 2001 International Sepsis Definitions
Conference to improve the traditional classification of
sepsis [52, 53]. PIRO systems incorporate assessment of
premorbid baseline susceptibility (predisposition), specific
disorders responsible for illness (infection), responses of
the host, and resulting degree of organ dysfunction. PIRO
scores have been developed in patients with severe sepsis
[54], community-acquired pneumonia (CAP) [55], and
ventilator-associated pneumonia [56]. Evaluation in septic
patients (25% intra-abdominal sepsis) in the emergency
department suggested the PIRO score had a significantly
improved AUC than both APACHE II and Mortality in
the Emergency Department scores [51]. In Calgary, the
CPIRO score showed consistent mortality discrimination
outperforming both APACHE II and SOFA [57]. The
mortality rate by CPIRO score was 37.6% for a
CPIRO of 4 and 54.7% for a CPIRO of 5 during its
development, and when tested with the Helsinki data,
it had the highest AUC.
Another tool to potentially identify patients with intra-
abdominal sepsis at a high risk of death is a World
Society of Emergency Surgery Sepsis Severity Score of 8
points or more [7]. The World Society of Emergency
Surgery (WSES) derived the WSESSSS from data and
experience obtained from a global prospective observa-
tional study (CIAOW Study) that recruited patients in
132 medical institutions located in 54 countries [16, 17].
Seven hundred ninety-one patients (17.4%) were admit-
ted in critical condition (septic shock or severe sepsis
according to Sepsis-2 definitions [52]). The most signifi-
cant variables, adjusted to clinical criteria, were used to
create a severity score for patients with complicated
intra-abdominal infections (cIAIs) including clinical
conditions at admission (severe sepsis/septic shock), the
origin of the cIAIs, the delay in source control, the
setting of acquisition, and any risk factors such as age
and immunosuppression. This predictive system carries
the advantage of having been validated in a different
worldwide population, giving great generalizability to the
scoring system. In general, a score above 5.5 was the
best predictor of mortality, but scores of 8 or more had
a 41.7% mortality [7], very comparable to other groups
of patients presenting with septic shock.
Combining the formal SOFA score with the WSESSSS
had a marginally higher detection rate than combining the
WSESSS, CPIRO, and septic shock (83.9 versus 82.8%).
Practical considerations that both the CPIRO and
WSESSS were designed to be used early in sepsis and
include expanded patient-specific criteria that do not
require periods of observation undergoing critical care
were felt to mitigate the marginally improved detection of
alternatively using the SOFA as an early marker. The
qSOFA was developed as a simple clinical criterion to
identify patients with suspected infection who were likely
to have poor outcomes, but it was also suggested that this
might constitute entry criteria for clinical trials, which the
COOL investigators strongly considered. However, the
qSOFA actually had the lowest AUC of the systems for-
mally tested and one of the lowest prediction rates in this
population. This finding in conjunction with a growing
opinion that the qSOFA may not be sensitive enough tool
for its intended purpose [39, 58–60] led the COOL advis-
ory panel to remove this inclusion criteria from the study
protocol. Nonetheless, a triggering of qSOFA criteria in
any patient with complicated IAS who may require opera-
tive source control should alert the caregivers to assess fur-
ther whether critical features of SCIAS are present (Fig. 3).
Conclusion
No one scoring system behaves perfectly, and all appear
to be largely dominated by organ dysfunction. Utilizing
both the CPIRO and WSESSSS scores in addition to the
Sepsis-3 septic shock definition, combining the SOFA
score with WSESSSS to detect seriously ill patients with
Table 5 Previous assessments of predictive capabilities of sepsis scoring systems (Continued)
Population Inclusion criteria Scores tested Outcome 1 Outcome 2 (if applicable)
MPI 0.60 AUC 0.52 AUC
SOFA 0.72 AUC 0.55 AUC
MODS 0.76 AUC 0.55 AUC
APS 0.68 AUC .60 AUC
ED emergency department; NEWS National Early Warning Score; Sepsis 1 use of the First Sepsis Consensus Definitions [61]; SENS sensitivity; Sepsis-3 use of the
Third Sepsis Consensus Definitions [2]; qSOFA quick SOFA score as per Sepsis-3 [2]; SOFA Sepsis-related Organ Failure Assessment [62]; AUC area under the curve
of a receiver/operator curve; SIRS Systemic Inflammatory Response Syndrome Criteria as per Sepsis-1 consensus definitions [61]; APACHE II Acute Physiology and
Chronic Health Evaluation II [31]; MPI Mannheim Peritonitis Index [41]; SAPS Simplified Acute Physiology Score [33]; SSS Sepsis Severity Score [33]; MOF multiple
organ failure [35]; TISS-28 Therapeutic Intervention Scoring System [38]; IAS intra-abdominal sepsis; APACHE-IV Acute Physiology and Chronic Health Evaluation IV
[63]; SCL Source Control Laparotomy; SAPS-II Simplified Acute Physiology Score-II [64]; P-POSSUM Physiological and Operative Severity Score for the enumeration
of Mortality and morbidity [36]; APS physiological part extracted from APACHE II [31]; MODS Multiple Organ Dysfunction Syndrome
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IAS, offered the widest “net” to recognize patients with a
high chance of mortality and ICU admission. Given
practical considerations, utilizing septic shock, CPIRO,
and WSESSS will form the basis of patient recruitment
into the COOL study in an additive fashion wherein pa-
tients meeting any of the severity score criterion will be
eligible (Fig. 2). The qSOFA score was considered insuf-
ficiently sensitive to serve as an eligibility criterion but
will nonetheless remain useful in a preoperative setting
to identify patients who require further evaluation, in-
vestigation, and care and might be eligible with further
information. Overall, efforts to refine predictive scoring
will benefit investigators looking to optimize inception
cohorts among other scientists attempting to understand
and treat SCIAS.
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